Literature DB >> 21118923

Different allele prevalence in the dihydrofolate reductase and dihydropteroate synthase genes in Plasmodium vivax populations from China.

Miao Miao1, Zhaoqing Yang, Long Cui, Jessica Ahlum, Yaming Huang, Liwang Cui.   

Abstract

Antifolate resistance in Plasmodium vivax is caused by point mutations in genes encoding dihydrofolate reductase (pvdhfr) and dihydropteroate synthase (pvdhps). In this study, we used direct sequencing to survey pvdhfr and pvdhps mutations in 122 clinical P. vivax isolates from a central and a southern province of China. For pvdhfr, 36.9% were wild-type, whereas mutations were detected at four codons (57, 58, 61, and 117). The S117N/T mutation was the most prevalent (48.4%), followed by the T61M mutation (18.9%). Six pvdhfr mutant alleles were found, ranging from 37.7% to 0.8%. The dramatically different pvdhfr allele frequencies between the two P. vivax populations might be caused by different drug histories or intrinsic difference between temperate and subtropical strains. In contrast, except polymorphisms within a repeat region, no resistance-conferring mutations were detected in pvdhps. Our result suggests that P. vivax populations in China may be relatively susceptible to sulfadoxine-pyrimethamine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118923      PMCID: PMC2990033          DOI: 10.4269/ajtmh.2010.10-0259

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  41 in total

1.  Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs.

Authors:  Alyson Auliff; Danny W Wilson; Bruce Russell; Qi Gao; Nanhua Chen; Le Ngoc Anh; Jason Maguire; David Bell; Michael T O'Neil; Qin Cheng
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

2.  Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.

Authors:  Michele D Hastings; Jason D Maguire; Michael J Bangs; Peter A Zimmerman; John C Reeder; J Kevin Baird; Carol Hopkins Sibley
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.

Authors:  Suminder Kaur; Surendra K Prajapati; Kavitha Kalyanaraman; Asif Mohmmed; Hema Joshi; Virander S Chauhan
Journal:  Acta Trop       Date:  2005-11-23       Impact factor: 3.112

4.  Pyrimethamine resistance in Plasmodium vivax malaria.

Authors:  M D YOUNG; R W BURGESS
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

Review 5.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

6.  Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase.

Authors:  Vivian N Hawkins; Stephanie M Suzuki; Kanchana Rungsihirunrat; Hapuarachchige C Hapuarachchi; Amanda Maestre; Kesara Na-Bangchang; Carol Hopkins Sibley
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

7.  Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance.

Authors:  P E de Pécoulas; R Tahar; T Ouatas; A Mazabraud; L K Basco
Journal:  Mol Biochem Parasitol       Date:  1998-05-01       Impact factor: 1.759

8.  Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.

Authors:  Kanchana Rungsihirunrat; Kesara Na-Bangchang; Vivian N Hawkins; Mathirut Mungthin; Carol Hopkins Sibley
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

9.  Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site.

Authors:  Michael Korsinczky; Katja Fischer; Nanhua Chen; Joanne Baker; Karl Rieckmann; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates.

Authors:  Sara Brega; Frédérique de Monbrison; Carlo Severini; Rachanee Udomsangpetch; Inge Sutanto; Paul Ruckert; François Peyron; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

View more
  10 in total

1.  Prevalence of antifolate drug resistance markers in Plasmodium vivax in China.

Authors:  Fang Huang; Yanwen Cui; He Yan; Hui Liu; Xiangrui Guo; Guangze Wang; Shuisen Zhou; Zhigui Xia
Journal:  Front Med       Date:  2022-03-07       Impact factor: 4.592

2.  Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.

Authors:  Feng Lu; Bo Wang; Jun Cao; Jetsumon Sattabongkot; Huayun Zhou; Guoding Zhu; Kwonkee Kim; Qi Gao; Eun-Taek Han
Journal:  Korean J Parasitol       Date:  2012-11-26       Impact factor: 1.341

3.  Plasmodium vivax populations revisited: mitochondrial genomes of temperate strains in Asia suggest ancient population expansion.

Authors:  Miao Miao; Zhaoqing Yang; Harland Patch; Yaming Huang; Ananias A Escalante; Liwang Cui
Journal:  BMC Evol Biol       Date:  2012-02-17       Impact factor: 3.260

4.  Monitoring resistance of Plasmdium vivax: point mutations in dihydrofolate reductase gene in isolates from Central China.

Authors:  Fang Huang; Shuisen Zhou; Shaosen Zhang; Weidong Li; Hongwei Zhang
Journal:  Parasit Vectors       Date:  2011-05-17       Impact factor: 3.876

5.  Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.

Authors:  Irina T Jovel; Rosa E Mejía; Engels Banegas; Rita Piedade; Jackeline Alger; Gustavo Fontecha; Pedro E Ferreira; Maria I Veiga; Irma G Enamorado; Anders Bjorkman; Johan Ursing
Journal:  Malar J       Date:  2011-12-19       Impact factor: 2.979

6.  Molecular Surveillance and Ex Vivo Drug Susceptibilities of Plasmodium vivax Isolates From the China-Myanmar Border.

Authors:  Weilin Zeng; Hui Zhao; Wei Zhao; Qi Yang; Xinxin Li; Xiaosong Li; Mengxi Duan; Xun Wang; Cuiying Li; Zheng Xiang; Xi Chen; Liwang Cui; Zhaoqing Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-01       Impact factor: 5.293

Review 7.  Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.

Authors:  Liwang Cui; Sungano Mharakurwa; Daouda Ndiaye; Pradipsinh K Rathod; Philip J Rosenthal
Journal:  Am J Trop Med Hyg       Date:  2015-08-10       Impact factor: 2.345

8.  Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China.

Authors:  Bo Huang; Shiguang Huang; Xin-zhuan Su; Xinxin Tong; Junping Yan; Hongbin Li; Fangli Lu
Journal:  Malar J       Date:  2014-09-02       Impact factor: 2.979

9.  A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax.

Authors:  C Brandon Ogbunugafor; Daniel Hartl
Journal:  Malar J       Date:  2016-01-25       Impact factor: 2.979

10.  Molecular surveillance for drug resistance markers in Plasmodium vivax isolates from symptomatic and asymptomatic infections at the China-Myanmar border.

Authors:  Yan Zhao; Lin Wang; Myat Thu Soe; Pyae Linn Aung; Haichao Wei; Ziling Liu; Tongyu Ma; Yuanyuan Huang; Lynette J Menezes; Qinghui Wang; Myat Phone Kyaw; Myat Htut Nyunt; Liwang Cui; Yaming Cao
Journal:  Malar J       Date:  2020-08-05       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.